18469854. TRANSCUTANEOUS VAGUS NERVE STIMULATION simplified abstract (Covidien LP)
Contents
- 1 TRANSCUTANEOUS VAGUS NERVE STIMULATION
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 TRANSCUTANEOUS VAGUS NERVE STIMULATION - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Original Abstract Submitted
TRANSCUTANEOUS VAGUS NERVE STIMULATION
Organization Name
Inventor(s)
Mark P. Ashby of Laguna Niguel CA (US)
Varun Umesh Kashyap of Palo Alto CA (US)
Scott R. Stanslaski of Shoreview MN (US)
David J. Miller of Austin TX (US)
Erik P. Fahimi of Aliso Viejo CA (US)
TRANSCUTANEOUS VAGUS NERVE STIMULATION - A simplified explanation of the abstract
This abstract first appeared for US patent application 18469854 titled 'TRANSCUTANEOUS VAGUS NERVE STIMULATION
Simplified Explanation
The patent application describes a system with a collar that includes two stimulating electrode arrays and a sensor array to deliver stimulation therapy and detect laryngeal muscle activity in a patient.
- The system includes a collar with stimulating electrode arrays and a sensor array.
- The first stimulating electrode array delivers stimulation therapy to the patient.
- The second stimulating electrode array also delivers stimulation therapy to the patient.
- The sensor array detects features indicative of laryngeal muscle activity.
- A controller manages the delivery of stimulation therapy through the electrode arrays.
Potential Applications
This technology could be applied in medical settings for patients with conditions affecting laryngeal muscle activity, such as dysphagia or vocal cord paralysis.
Problems Solved
This technology helps in monitoring and treating laryngeal muscle activity disorders, providing targeted stimulation therapy to improve patient outcomes.
Benefits
The system offers a non-invasive and targeted approach to treating laryngeal muscle activity disorders, potentially improving patient quality of life.
Potential Commercial Applications
"Collar System for Laryngeal Muscle Stimulation Therapy: Potential Commercial Applications"
Possible Prior Art
There may be prior art related to similar systems used for laryngeal muscle stimulation therapy, but specific examples are not provided in the abstract.
Unanswered Questions
== How does the system differentiate between different types of laryngeal muscle activity disorders in patients? The abstract does not specify how the sensor array distinguishes between various types of laryngeal muscle activity disorders.
== What is the expected timeline for the development and commercialization of this technology? The abstract does not mention any details regarding the timeline for the development and commercialization of the system.
Original Abstract Submitted
An example system includes a collar; a first stimulating electrode array positioned on the collar and configured to delivery stimulation therapy to a patient; a second stimulating electrode array being positioned on the collar and configured to deliver stimulation therapy to the patient; a sensor array being positioned on the collar and configured to detect one or more features indicative of laryngeal muscle activity of the patient; and a controller configured to control stimulation therapy to be delivered via the first stimulating electrode array and the second stimulating electrode array.
